Inmar Intelligence will offer advanced in-store advertising solutions for consumer packaged goods partners at Ahold Delhaize ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

In a report released today, Sreedhar Mahamkali from UBS maintained a Sell rating on Koninklijke Ahold Delhaize N.V. (0RI8 – Research Report), with a price target of €28.00. The company’s sha ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The letter is addressed to Frans Muller, President & CEO of Ahold Delhaize Netherlands, and J.J. Fleeman, CEO of Ahold Delhaize US. The treasurers - Deborah B. Goldberg of Massachusetts ...

2025 marks the first full year of Ahold Delhaize’s Growing Together strategy. Focusing on its financial expectations, the company aims to deliver both organic and inorganic sales growth. The company ...

Additionally, former Sobeys President and CEO Bill McEwan, the board’s vice chair, will step down during the upcoming AGM after having served on Delhaize Group’s and Ahold Delhaize’s supervisory ...

The Netherlands is full of stunning forests that offer the perfect escape from the rush of the Randstad. A leisurely walk around a forest in Holland is the ideal way to relax, breathe, and even spot ...

Moving to the Netherlands offers a number of challenges: from navigating the housing crisis to registering yourself — and you’ve beat them all! But now, there’s one more challenge. How do you set up ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

SALISBURY, N.C., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ahold Delhaize USA has reaffirmed its commitment to data-driven growth by renewing its strategic partnership with Circana, LLC. This renewal ...

ABP has also sold its stakes in pharmaceutical companies Johnson & Johnson and AstraZeneca, halved its portfolio invested in Israeli companies, and ditched Ahold and Philips. Its investments in ...